The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Diagnostic Radiopharmaceuticals Market Research Report 2024
Synopsis
Radiopharmaceuticals refer to a class of special medicines containing radionuclides for medical diagnosis and treatment. Compounds or biological preparations containing radionuclide labels used for medical diagnosis or treatment in the body. Diagnostic radiopharmaceuticals are radioisotopes that bind to biomolecules that can locate specific organs, tissues or cells in the body. These radiopharmaceuticals can be used to diagnose diseases.
The global Diagnostic Radiopharmaceuticals market was valued at US$ 4385.1 million in 2023 and is anticipated to reach US$ 7034 million by 2030, witnessing a CAGR of 6.9% during the forecast period 2024-2030.
North America is the world's major consumer region, with sales accounting for 41.59% of the global total in 2019. Europe is also a major consumer region, accounting for 24.5% of the global market. China is also a very important consumer region due to the large number of cancers. At present, products represented by Cardinal Health, GE Healthcare, Curium Pharma, Jubilant Pharma, Bracco Imaging, etc. occupy a major position in the global market.
This report aims to provide a comprehensive presentation of the global market for Diagnostic Radiopharmaceuticals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diagnostic Radiopharmaceuticals.
Report Scope
The Diagnostic Radiopharmaceuticals market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Diagnostic Radiopharmaceuticals market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diagnostic Radiopharmaceuticals manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Cardinal Health
GE Healthcare
Curium Pharma
Jubilant Pharma
Bracco Imaging
Advanced Accelerator Applications
SIEMENS
China Isotope & Radiation
Dongcheng Pharmaceutical Group
Lantheus
Eli Lilly
Segment by Type
Technetium 99
Fluorine 18
Other
Segment by Application
Oncology
Cardiology
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Diagnostic Radiopharmaceuticals manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Diagnostic Radiopharmaceuticals in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Radiopharmaceuticals refer to a class of special medicines containing radionuclides for medical diagnosis and treatment. Compounds or biological preparations containing radionuclide labels used for medical diagnosis or treatment in the body. Diagnostic radiopharmaceuticals are radioisotopes that bind to biomolecules that can locate specific organs, tissues or cells in the body. These radiopharmaceuticals can be used to diagnose diseases.
The global Diagnostic Radiopharmaceuticals market was valued at US$ 4385.1 million in 2023 and is anticipated to reach US$ 7034 million by 2030, witnessing a CAGR of 6.9% during the forecast period 2024-2030.
North America is the world's major consumer region, with sales accounting for 41.59% of the global total in 2019. Europe is also a major consumer region, accounting for 24.5% of the global market. China is also a very important consumer region due to the large number of cancers. At present, products represented by Cardinal Health, GE Healthcare, Curium Pharma, Jubilant Pharma, Bracco Imaging, etc. occupy a major position in the global market.
This report aims to provide a comprehensive presentation of the global market for Diagnostic Radiopharmaceuticals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diagnostic Radiopharmaceuticals.
Report Scope
The Diagnostic Radiopharmaceuticals market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Diagnostic Radiopharmaceuticals market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diagnostic Radiopharmaceuticals manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Cardinal Health
GE Healthcare
Curium Pharma
Jubilant Pharma
Bracco Imaging
Advanced Accelerator Applications
SIEMENS
China Isotope & Radiation
Dongcheng Pharmaceutical Group
Lantheus
Eli Lilly
Segment by Type
Technetium 99
Fluorine 18
Other
Segment by Application
Oncology
Cardiology
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Diagnostic Radiopharmaceuticals manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Diagnostic Radiopharmaceuticals in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Diagnostic Radiopharmaceuticals Market Overview
1.1 Product Overview and Scope of Diagnostic Radiopharmaceuticals
1.2 Diagnostic Radiopharmaceuticals Segment by Type
1.2.1 Global Diagnostic Radiopharmaceuticals Market Value Comparison by Type (2024-2030)
1.2.2 Technetium 99
1.2.3 Fluorine 18
1.2.4 Other
1.3 Diagnostic Radiopharmaceuticals Segment by Application
1.3.1 Global Diagnostic Radiopharmaceuticals Market Value by Application: (2024-2030)
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Other
1.4 Global Diagnostic Radiopharmaceuticals Market Size Estimates and Forecasts
1.4.1 Global Diagnostic Radiopharmaceuticals Revenue 2019-2030
1.4.2 Global Diagnostic Radiopharmaceuticals Sales 2019-2030
1.4.3 Global Diagnostic Radiopharmaceuticals Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Diagnostic Radiopharmaceuticals Market Competition by Manufacturers
2.1 Global Diagnostic Radiopharmaceuticals Sales Market Share by Manufacturers (2019-2024)
2.2 Global Diagnostic Radiopharmaceuticals Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Diagnostic Radiopharmaceuticals Average Price by Manufacturers (2019-2024)
2.4 Global Diagnostic Radiopharmaceuticals Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Diagnostic Radiopharmaceuticals, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Diagnostic Radiopharmaceuticals, Product Type & Application
2.7 Diagnostic Radiopharmaceuticals Market Competitive Situation and Trends
2.7.1 Diagnostic Radiopharmaceuticals Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Diagnostic Radiopharmaceuticals Players Market Share by Revenue
2.7.3 Global Diagnostic Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Diagnostic Radiopharmaceuticals Retrospective Market Scenario by Region
3.1 Global Diagnostic Radiopharmaceuticals Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Diagnostic Radiopharmaceuticals Global Diagnostic Radiopharmaceuticals Sales by Region: 2019-2030
3.2.1 Global Diagnostic Radiopharmaceuticals Sales by Region: 2019-2024
3.2.2 Global Diagnostic Radiopharmaceuticals Sales by Region: 2025-2030
3.3 Global Diagnostic Radiopharmaceuticals Global Diagnostic Radiopharmaceuticals Revenue by Region: 2019-2030
3.3.1 Global Diagnostic Radiopharmaceuticals Revenue by Region: 2019-2024
3.3.2 Global Diagnostic Radiopharmaceuticals Revenue by Region: 2025-2030
3.4 North America Diagnostic Radiopharmaceuticals Market Facts & Figures by Country
3.4.1 North America Diagnostic Radiopharmaceuticals Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Diagnostic Radiopharmaceuticals Sales by Country (2019-2030)
3.4.3 North America Diagnostic Radiopharmaceuticals Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Diagnostic Radiopharmaceuticals Market Facts & Figures by Country
3.5.1 Europe Diagnostic Radiopharmaceuticals Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Diagnostic Radiopharmaceuticals Sales by Country (2019-2030)
3.5.3 Europe Diagnostic Radiopharmaceuticals Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Diagnostic Radiopharmaceuticals Market Facts & Figures by Country
3.6.1 Asia Pacific Diagnostic Radiopharmaceuticals Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Diagnostic Radiopharmaceuticals Sales by Country (2019-2030)
3.6.3 Asia Pacific Diagnostic Radiopharmaceuticals Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Diagnostic Radiopharmaceuticals Market Facts & Figures by Country
3.7.1 Latin America Diagnostic Radiopharmaceuticals Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Diagnostic Radiopharmaceuticals Sales by Country (2019-2030)
3.7.3 Latin America Diagnostic Radiopharmaceuticals Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Diagnostic Radiopharmaceuticals Market Facts & Figures by Country
3.8.1 Middle East and Africa Diagnostic Radiopharmaceuticals Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Diagnostic Radiopharmaceuticals Sales by Country (2019-2030)
3.8.3 Middle East and Africa Diagnostic Radiopharmaceuticals Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Diagnostic Radiopharmaceuticals Sales by Type (2019-2030)
4.1.1 Global Diagnostic Radiopharmaceuticals Sales by Type (2019-2024)
4.1.2 Global Diagnostic Radiopharmaceuticals Sales by Type (2025-2030)
4.1.3 Global Diagnostic Radiopharmaceuticals Sales Market Share by Type (2019-2030)
4.2 Global Diagnostic Radiopharmaceuticals Revenue by Type (2019-2030)
4.2.1 Global Diagnostic Radiopharmaceuticals Revenue by Type (2019-2024)
4.2.2 Global Diagnostic Radiopharmaceuticals Revenue by Type (2025-2030)
4.2.3 Global Diagnostic Radiopharmaceuticals Revenue Market Share by Type (2019-2030)
4.3 Global Diagnostic Radiopharmaceuticals Price by Type (2019-2030)
5 Segment by Application
5.1 Global Diagnostic Radiopharmaceuticals Sales by Application (2019-2030)
5.1.1 Global Diagnostic Radiopharmaceuticals Sales by Application (2019-2024)
5.1.2 Global Diagnostic Radiopharmaceuticals Sales by Application (2025-2030)
5.1.3 Global Diagnostic Radiopharmaceuticals Sales Market Share by Application (2019-2030)
5.2 Global Diagnostic Radiopharmaceuticals Revenue by Application (2019-2030)
5.2.1 Global Diagnostic Radiopharmaceuticals Revenue by Application (2019-2024)
5.2.2 Global Diagnostic Radiopharmaceuticals Revenue by Application (2025-2030)
5.2.3 Global Diagnostic Radiopharmaceuticals Revenue Market Share by Application (2019-2030)
5.3 Global Diagnostic Radiopharmaceuticals Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Cardinal Health
6.1.1 Cardinal Health Corporation Information
6.1.2 Cardinal Health Description and Business Overview
6.1.3 Cardinal Health Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Cardinal Health Diagnostic Radiopharmaceuticals Product Portfolio
6.1.5 Cardinal Health Recent Developments/Updates
6.2 GE Healthcare
6.2.1 GE Healthcare Corporation Information
6.2.2 GE Healthcare Description and Business Overview
6.2.3 GE Healthcare Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GE Healthcare Diagnostic Radiopharmaceuticals Product Portfolio
6.2.5 GE Healthcare Recent Developments/Updates
6.3 Curium Pharma
6.3.1 Curium Pharma Corporation Information
6.3.2 Curium Pharma Description and Business Overview
6.3.3 Curium Pharma Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Curium Pharma Diagnostic Radiopharmaceuticals Product Portfolio
6.3.5 Curium Pharma Recent Developments/Updates
6.4 Jubilant Pharma
6.4.1 Jubilant Pharma Corporation Information
6.4.2 Jubilant Pharma Description and Business Overview
6.4.3 Jubilant Pharma Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Jubilant Pharma Diagnostic Radiopharmaceuticals Product Portfolio
6.4.5 Jubilant Pharma Recent Developments/Updates
6.5 Bracco Imaging
6.5.1 Bracco Imaging Corporation Information
6.5.2 Bracco Imaging Description and Business Overview
6.5.3 Bracco Imaging Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Bracco Imaging Diagnostic Radiopharmaceuticals Product Portfolio
6.5.5 Bracco Imaging Recent Developments/Updates
6.6 Advanced Accelerator Applications
6.6.1 Advanced Accelerator Applications Corporation Information
6.6.2 Advanced Accelerator Applications Description and Business Overview
6.6.3 Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Product Portfolio
6.6.5 Advanced Accelerator Applications Recent Developments/Updates
6.7 SIEMENS
6.6.1 SIEMENS Corporation Information
6.6.2 SIEMENS Description and Business Overview
6.6.3 SIEMENS Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.4.4 SIEMENS Diagnostic Radiopharmaceuticals Product Portfolio
6.7.5 SIEMENS Recent Developments/Updates
6.8 China Isotope & Radiation
6.8.1 China Isotope & Radiation Corporation Information
6.8.2 China Isotope & Radiation Description and Business Overview
6.8.3 China Isotope & Radiation Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.8.4 China Isotope & Radiation Diagnostic Radiopharmaceuticals Product Portfolio
6.8.5 China Isotope & Radiation Recent Developments/Updates
6.9 Dongcheng Pharmaceutical Group
6.9.1 Dongcheng Pharmaceutical Group Corporation Information
6.9.2 Dongcheng Pharmaceutical Group Description and Business Overview
6.9.3 Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Product Portfolio
6.9.5 Dongcheng Pharmaceutical Group Recent Developments/Updates
6.10 Lantheus
6.10.1 Lantheus Corporation Information
6.10.2 Lantheus Description and Business Overview
6.10.3 Lantheus Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Lantheus Diagnostic Radiopharmaceuticals Product Portfolio
6.10.5 Lantheus Recent Developments/Updates
6.11 Eli Lilly
6.11.1 Eli Lilly Corporation Information
6.11.2 Eli Lilly Diagnostic Radiopharmaceuticals Description and Business Overview
6.11.3 Eli Lilly Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Eli Lilly Diagnostic Radiopharmaceuticals Product Portfolio
6.11.5 Eli Lilly Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Diagnostic Radiopharmaceuticals Industry Chain Analysis
7.2 Diagnostic Radiopharmaceuticals Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Diagnostic Radiopharmaceuticals Production Mode & Process
7.4 Diagnostic Radiopharmaceuticals Sales and Marketing
7.4.1 Diagnostic Radiopharmaceuticals Sales Channels
7.4.2 Diagnostic Radiopharmaceuticals Distributors
7.5 Diagnostic Radiopharmaceuticals Customers
8 Diagnostic Radiopharmaceuticals Market Dynamics
8.1 Diagnostic Radiopharmaceuticals Industry Trends
8.2 Diagnostic Radiopharmaceuticals Market Drivers
8.3 Diagnostic Radiopharmaceuticals Market Challenges
8.4 Diagnostic Radiopharmaceuticals Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
